CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,315,193 | -18.4% | 112,532 | -9.7% | 0.00% | -25.0% |
| Q2 2023 | $4,063,082 | +13.5% | 124,558 | +22.5% | 0.00% | 0.0% |
| Q1 2023 | $3,578,295 | -20.6% | 101,685 | +3.4% | 0.00% | -20.0% |
| Q4 2022 | $4,504,656 | -4.8% | 98,312 | +0.7% | 0.01% | 0.0% |
| Q3 2022 | $4,732,000 | +28.8% | 97,657 | +4.4% | 0.01% | +25.0% |
| Q2 2022 | $3,674,000 | +6.3% | 93,502 | -0.4% | 0.00% | +33.3% |
| Q1 2022 | $3,455,000 | -11.8% | 93,854 | +9.2% | 0.00% | +50.0% |
| Q4 2021 | $3,917,000 | +26.6% | 85,938 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $3,095,000 | +60.3% | 86,583 | -11.3% | 0.00% | +100.0% |
| Q2 2021 | $1,931,000 | -31.7% | 97,567 | -19.8% | 0.00% | 0.0% |
| Q1 2021 | $2,829,000 | -27.9% | 121,608 | -35.6% | 0.00% | -50.0% |
| Q4 2020 | $3,923,000 | +38.3% | 188,760 | +44.1% | 0.00% | 0.0% |
| Q3 2020 | $2,836,000 | +41.6% | 130,973 | +54.1% | 0.00% | +100.0% |
| Q2 2020 | $2,003,000 | +539.9% | 84,991 | +219.9% | 0.00% | – |
| Q1 2020 | $313,000 | -14.9% | 26,564 | -23.2% | 0.00% | – |
| Q4 2019 | $368,000 | -47.1% | 34,603 | -43.4% | 0.00% | -100.0% |
| Q3 2019 | $695,000 | +110.0% | 61,093 | +107.6% | 0.00% | – |
| Q2 2019 | $331,000 | +30.8% | 29,430 | -6.2% | 0.00% | – |
| Q1 2019 | $253,000 | +69.8% | 31,378 | +33.4% | 0.00% | – |
| Q4 2018 | $149,000 | -14.9% | 23,528 | +32.6% | 0.00% | – |
| Q3 2018 | $175,000 | -32.4% | 17,738 | -43.0% | 0.00% | – |
| Q2 2018 | $259,000 | -2.6% | 31,145 | -15.9% | 0.00% | – |
| Q1 2018 | $266,000 | +1.5% | 37,016 | +15.2% | 0.00% | – |
| Q4 2017 | $262,000 | -66.6% | 32,129 | -40.6% | 0.00% | -100.0% |
| Q3 2017 | $784,000 | +46.0% | 54,110 | +21.8% | 0.00% | 0.0% |
| Q2 2017 | $537,000 | +38.4% | 44,422 | +47.2% | 0.00% | – |
| Q1 2017 | $388,000 | +55.8% | 30,178 | +47.4% | 0.00% | – |
| Q4 2016 | $249,000 | -16.2% | 20,479 | -36.6% | 0.00% | – |
| Q3 2016 | $297,000 | +37.5% | 32,311 | +41.5% | 0.00% | – |
| Q2 2016 | $216,000 | +8.5% | 22,839 | -19.2% | 0.00% | – |
| Q1 2016 | $199,000 | -58.1% | 28,260 | -37.7% | 0.00% | -100.0% |
| Q4 2015 | $475,000 | +427.8% | 45,370 | +236.3% | 0.00% | – |
| Q3 2015 | $90,000 | -11.8% | 13,491 | -11.1% | 0.00% | – |
| Q2 2015 | $102,000 | -46.9% | 15,168 | -46.4% | 0.00% | – |
| Q1 2015 | $192,000 | -29.9% | 28,277 | -17.3% | 0.00% | – |
| Q4 2014 | $274,000 | +17.6% | 34,185 | -48.3% | 0.00% | – |
| Q3 2014 | $233,000 | -50.5% | 66,166 | -32.9% | 0.00% | – |
| Q2 2014 | $471,000 | +27.6% | 98,545 | +153.5% | 0.00% | – |
| Q1 2014 | $369,000 | -32.7% | 38,873 | -53.9% | 0.00% | – |
| Q4 2013 | $548,000 | +10.5% | 84,347 | +28.6% | 0.00% | – |
| Q3 2013 | $496,000 | – | 65,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |